Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Targovax is Invited to Present at Upcoming Investor Conferences | ||
| By: PR Newswire Association LLC. - 21 Jan 2019 | Back to overview list |
|
OSLO, Norway, Jan. 21, 2019 /PRNewswire/ -- Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, announces that members of its senior management team will present at upcoming investor conferences. Date: 22 January 2019 Venue: Redeye Fight Cancer Seminar, Stockholm, Sweden Presenter: Erik Digman Wiklund (CBO) Presentation: - Time: 10:45 CET Panel discussion: - The field of Immuno-oncology - how to optimize clinical development - what trends do you see in the market? - Time: 11:40 CET The event can be followed live here.The presentation will be available to download at www.targovax.com after the event. Date: 7 February 2019 Venue: 5th annual Immuno-oncology (IO) 360°, NYC, USA Presenter: Erik Digman Wiklund (CBO) Panel discussion: - Fundraising in the Current IO Space - Time: 11:10 AM EST For further information, please contact: Renate Birkeli Media and IR enquires: Andreas Tinglum Simon Conway/Stephanie Cuthbert This information was brought to you by Cision http://news.cision.com
SOURCE Targovax 
|
||
|
||
 | Back to overview list | |
View original content: